Creating knowledge from diabetes data
Creating knowledge from diabetes data
Creating
knowledge from
diabetes data
OneTwo Analytics is transforming global diabetes care with AI-driven solutions. Our innovative tools provide healthcare professionals with valuable insights for personalized and efficient care, while also offering tailored solutions for stakeholders in the diabetes care sector.
OneTwo Analytics is transforming global diabetes care with AI-driven solutions. Our innovative tools provide healthcare professionals with valuable insights for personalized and efficient care, while also offering tailored solutions for stakeholders in the diabetes care sector.
OneTwo Analytics is transforming global diabetes care with AI-driven solutions. Our innovative tools provide healthcare professionals with valuable insights for personalized and efficient care, while also offering tailored solutions for stakeholders in the diabetes care sector.
Promising Early Results in Type 1 Diabetes Research!
Promising Early Results in Type 1 Diabetes Research!
Promising Early Results in Type 1 Diabetes Research!
Our co-founder and CMO, Professor Per-Ola Carlsson, is a leading researcher in the field of type 1 diabetes. His cutting-edge research explores the potential of genetically modified, hypoimmune insulin-producing cells from the Islets of Langerhans as a cure for type 1 diabetes. Here is what he has to say about his research:
“We’ve demonstrated that genetically modified islet cells can safely survive and produce insulin in people with type 1 diabetes- without the need for immunosuppression. These early results are a major step in our research for a cure.”
While the search for a cure continues, Professor Carlsson is also dedicated to improving diabetes care:
“My long-term goal is to be able to bring a cure for type 1 diabetes but in the meantime, I strive to improve the clinical management of diabetes and daily life for everyone living with diabetes by developing digital solutions that can automate the interpretation of diabetes data.”
Read more about the research here.
Our co-founder and CMO, Professor Per-Ola Carlsson, is a leading researcher in the field of type 1 diabetes. His cutting-edge research explores the potential of genetically modified, hypoimmune insulin-producing cells from the Islets of Langerhans as a cure for type 1 diabetes. Here is what he has to say about his research:
“We’ve demonstrated that genetically modified islet cells can safely survive and produce insulin in people with type 1 diabetes- without the need for immunosuppression. These early results are a major step in our research for a cure.”
While the search for a cure continues, Professor Carlsson is also dedicated to improving diabetes care:
“My long-term goal is to be able to bring a cure for type 1 diabetes but in the meantime, I strive to improve the clinical management of diabetes and daily life for everyone living with diabetes by developing digital solutions that can automate the interpretation of diabetes data.”
Read more about the research here.
Our co-founder and CMO, Professor Per-Ola Carlsson, is a leading researcher in the field of type 1 diabetes. His cutting-edge research explores the potential of genetically modified, hypoimmune insulin-producing cells from the Islets of Langerhans as a cure for type 1 diabetes. Here is what he has to say about his research:
“We’ve demonstrated that genetically modified islet cells can safely survive and produce insulin in people with type 1 diabetes- without the need for immunosuppression. These early results are a major step in our research for a cure.”
While the search for a cure continues, Professor Carlsson is also dedicated to improving diabetes care:
“My long-term goal is to be able to bring a cure for type 1 diabetes but in the meantime, I strive to improve the clinical management of diabetes and daily life for everyone living with diabetes by developing digital solutions that can automate the interpretation of diabetes data.”
Read more about the research here.
Partners
Partners
Partners
Beyond our own services, we also offer White-Label solutions for companies specializing in diabetes technologies, including Continuous Glucose Monitoring (CGM), insulin pumps, and other related devices. By partnering with us, we can shorten time to market, reduce development costs, and provide new features for data analysis.
Meet Per-Ola Carlsson, co-founder and CMO
Meet Per-Ola Carlsson, co-founder and CMO
Meet Per-Ola Carlsson, co-founder and CMO
Number of people living with diabetes globally and per region
(International Diabetes Federation) 2021
Diabetes in the world
Diabetes has become a global epidemic, with its prevalence reaching record levels in recent years. Currently, over 600 million people worldwide live with diabetes, and the number continues to rise at an alarming rate. OneTwo Analytics aims to set a new standard for diabetes care by enhancing efficiency and precision within the healthcare system.
OneTwo Diabetes – A personal diabetes assistant
Diabetes in the world
Diabetes in the world
OneTwo Diabetes is an app developed for people living with type 1 or type 2 diabetes and using a CGM sensor. OneTwo Diabetes is automatic, personalized, and free of charge!
Diabetes has become a global epidemic, with its prevalence reaching record levels in recent years. Currently, over 600 million people worldwide live with diabetes, and the number continues to rise at an alarming rate. OneTwo Analytics aims to set a new standard for diabetes care by enhancing efficiency and precision within the healthcare system.
Diabetes has become a global epidemic, with its prevalence reaching record levels in recent years. Currently, over 600 million people worldwide live with diabetes, and the number continues to rise at an alarming rate. OneTwo Analytics aims to set a new standard for diabetes care by enhancing efficiency and precision within the healthcare system.
Collaborative partners
We have a proud partnership with major players in diabetes and diabetes technology such as Karolinska Institutet Innovations AB, Sophiahemmet University College Stockholm, Sophiahemmet hospital in Stockholm, Diabetes Center Berne, Uppsala University in Sweden and Dexcom.
Read more about our research
Collaborative partners
We have a proud partnership with major players in diabetes and diabetes technology such as Karolinska Institutet Innovations AB, Sophiahemmet University College Stockholm, Sophiahemmet hospital in Stockholm, Diabetes Center Berne, Uppsala University in Sweden and Dexcom.
Read more about our research
Collaborative partners
We have a proud partnership with major players in diabetes and diabetes technology such as Karolinska Institutet Innovations AB, Sophiahemmet University College Stockholm, Sophiahemmet hospital in Stockholm, Diabetes Center Berne, Uppsala University in Sweden and Dexcom.
Read more about our research
Products
© One Two Analytics AB 2023
Products